Genetic Future
Commentary on human genetics and evolution, direct-to-consumer genetic testing, and the personal genomics industry.
Search
Profile
Daniel MacArthur
I write about the genetic and evolutionary basis of human variation, and the companies trying to sell you information about your genome.
Subscribe via RSS.
Follow me on Twitter.
Recent Posts
- What can you learn from a whole genome sequence?
- Guest post: Kai Wang on the McClellan and King critique of genome-wide association studies
- Genomes, Environments, Traits Conference: following at a distance
- Why disease associations outside of genes are not a bad thing
- Second sequenced family emerges from anonymity
- Recreational genome sequencing for the whole family
- Will the Myriad gene patent decision harm innovation in genomics?
- Nature special issue on genomics
- Common copy number variation doesn't explain much complex disease risk - but why not?
- "Jaw-dropping" verdict against Myriad in BRCA patent case
Recent Comments
- che on What can you learn from a whole genome sequence?
- Afterthought on What can you learn from a whole genome sequence?
- Kevin Mitchell on Guest post: Kai Wang on the McClellan and King critique of genome-wide association studies
- Rand on What can you learn from a whole genome sequence?
- Graham Philip on Guest post: Kai Wang on the McClellan and King critique of genome-wide association studies
- Graham Philip on Guest post: Kai Wang on the McClellan and King critique of genome-wide association studies
- 100M1D99M on What can you learn from a whole genome sequence?
- Susan Colilla on What can you learn from a whole genome sequence?
- Neil on Guest post: Kai Wang on the McClellan and King critique of genome-wide association studies
- keith grimaldi on Guest post: Kai Wang on the McClellan and King critique of genome-wide association studies
Archives
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
Blogs I read:
Consumer Genomics:
Genomic Science:
- Anthony Fejes
- David Dooling
- Dan Koboldt
- Luke Jostins
- Pathogenomics
- Jan Aerts
- Popgen Ramblings
- Adaptive Complexity
- Genomicron
Genetics/Evolution Blogs:
- Razib Khan
- John Hawks
- Gene Expression
- Eye on DNA
- Dienekes
- Yann Klimentidis
- European Genetics
- Discovering Biology in a Digital World
- The Genetic Genealogist
- business|bytes|genes|molecules
- Thomas Mailund
- John Halamka
General Science:
Corporate Blogs:
Skeptics:
About Genetic Future
In around five years, a complete genome sequence will be readily affordable for most citizens of wealthy industrialised nations - even those of us on a researcher's salary. At the same time we will have access to vast amounts of data about the effects of individual genetic variants on our future health. Storing, processing and using genetic data to make effective health decisions will become an immense challenge both to healthcare providers and to individual consumers.
The revolution has already begun: right now, "personal genomics" companies such as 23andMe, deCODEme and Navigenics offer to scan your genome for hundreds of thousands of common sites of variation, and to generate predictions about your risk of common diseases such as diabetes and arthritis. A horde of smaller companies also offer "boutique" genetic testing services for anything from hair loss to bipolar disorder. Some of these tests are valuable, while for others the scientific evidence is weak and the predictive value vanishingly small - but for the typical consumer it is difficult to discern the genuine offerings from the scams.
Genetic Future's primary mission is to cut through the hype associated with the brave new world of human genomics. I report on the latest findings from genome-wide association studies and large-scale sequencing projects investigating the genetic underpinnings of common disease, putting their results in context and in language that consumers can understand.
I also review the scientific basis and useability of products offered by commercial genetic testing companies. I'll be dissecting the studies used by these companies to justify their expensive tests, and describing in plain language how useful such tests are likely to be to consumers.
About Me
I'm an Australian researcher (now based in the UK) interested in the evolutionary origins of the genetic variants that underlie normal variation and common disease risk in modern humans.
I also have a long-standing personal fascination with the consumer genetic testing industry, and particularly in the shiny new field of personal genomics. When the $1000 genome sequence arrives, I'll be buying one - and I want to know what to do with it once I have it.
My older articles on human genetics and personal genomics are archived at the old Genetic Future site.
